Medine.co.uk

Out of date information, search another

Montelukast 5 Mg Chewable Tablets

Out of date information, search another
Informations for option: Montelukast 5 Mg Chewable Tablets, show other option
Document: document 10 change

a :ord


Use in children

Package leaflet: Information for the user

Montelukast 5 mg Chewable Tablets

For children from 6 to 14 years Montelukast

Read all of this leaflet carefully before you

start taking this medicine because it contains

important information for you.

•    Keep this leaflet. You may need to read it again.

•    If you have any further questions, ask your doctor or pharmacist or nurse.

•    This medicine has been prescribed for you or your child. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.

•    If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

1.    What montelukast chewable tablet 5 mg is and what it is used for

2.    What you need to know before you take montelukast chewable tablet 5 mg

3.    How to take montelukast chewable tablet 5 mg

4.    Possible side effects

5.    How to store montelukast chewable tablet 5 mg

6.    Contents of the pack and other information

1. What montelukast chewable tablet 5 mg is and what it is used for

Your doctor has prescribed, Montelukast chewable tablet to treat your or your child's asthma, preventing asthma symptoms during the day and night.

•    Montelukast chewable tablet is used for the treatment of patients who are not adequately controlled on their medication and need additional therapy.

•    Montelukast chewable tablet 5 mg may also be used as an alternative treatment to inhaled corticosteroids for 6 to 14 year old patients who have not recently taken oral corticosteroids for their asthma and have shown that they are unable to use inhaled corticosteroids.

•    Montelukast chewable tablet also helps prevent the narrowing of airways triggered by exercise for patients 6 years of age and older.

Your or your child's doctor will determine how montelukast chewable tablet should be used depending on the symptoms and severity of your or your child's asthma.

Montelukast chewable tablet is a leukotriene receptor antagonist that blocks substances called leukotrienes. Leukotrienes cause narrowing and swelling of airways in your lungs. By blocking leukotrienes, Montelukast chewable tablet improves asthma symptoms and helps control asthma.

What is asthma?

Asthma is a long-term disease.

Asthma includes:

•    Difficulty in breathing because of narrowed airways. This narrowing of airways worsens and improves in response to various conditions.

•    Sensitive airways that react to many things, such as cigarette smoke, pollen, cold air, or exercise.

•    Swelling (inflammation) in the lining of the airways.

Symptoms of asthma include: Coughing, wheezing, and chest tightness

2. What you need to know before you take montelukast chewable tablet 5 mg

Tell your or your child's doctor about any medical

problems or allergies you or your child has now

or has had.

Do not take montelukast chewable tablet 5 mg

•    If you or your child is allergic (hypersensitive) to montelukast, or any of the other ingredients of montelukast chewable tablet (see 6. Further information).

Warnings and precautions

•    Please tell your doctor immediately if you or your child's asthma or breathing gets worse.

•    Oral montelukast chewable tablet is not meant to treat acute asthma attacks. If an attack occurs, follow the instructions your doctor has given you or your child. Always have your or your child's inhaled rescue medicine for asthma attacks with you.

•    It is important that you or your child take all asthma medications prescribed by your doctor. Montelukast chewable tablet should not be used instead of other asthma medications your doctor has prescribed for you or your child.

•    If you or your child is on anti-asthma medicines, be aware that if you or your child develops a combination of symptoms such as flu-like illness, pins and needles or numbness of arms or legs, worsening of pulmonary symptoms, and/or rash, you should consult your doctor.

•    You or your child should not take acetyl-salicylic acid (aspirin) or anti-inflammatory medicines (also known as non-steroidal anti-inflammatory drugs or NSAIDs) if they make your or your child's asthma worse.

Montelukast 5 mg chewable tablets are available for children 6 to 14 years old.

Montelukast 4 mg chewable tablets are available for children 2 to 5 years old. Montelukast 4 mg chewable tablets are not recommended below 2 years of age.

Other medicines and montelukast chewable tablet 5 mg

Some medicines may affect how montelukast chewable tablet works, or montelukast chewable tablet may affect how other medicines work. Please tell your doctor or pharmacist if you or your child is taking or has recently taken other medicines, including those obtained without a prescription.

Tell your doctor if you or your child is taking the following medicines before starting montelukast chewable tablet:

•    phenobarbital (used for treatment of epilepsy)

•    phenytoin (used for treatment of epilepsy)

•    rifampicin (used to treat tuberculosis and some other infections)

Taking montelukast chewable tablet 5 mg with food and drink

Montelukast chewable tablet should not be taken immediately with food; they should be taken at least 1 hour before or 2 hours after food.

Pregnancy and breast-feeding

Use in pregnancy

Women who are pregnant or intend to become pregnant should consult their doctor before taking Montelukast chewable tablets. Your doctor will assess whether you can take Montelukast chewable tablet during this time.

Use in breast-feeding It is not known if montelukast is excreted in human milk. You should consult your doctor before taking Montelukast chewable tablets if you are breast-feeding or intend to breast-feed.

Driving and using machines

Montelukast chewable tablet is not expected to affect your ability to drive a car or operate machinery. However, individual responses to medication may vary. Certain side effects (such as dizziness and drowsiness) that have been reported very rarely with Montelukast chewable tablets may affect some patients' ability to drive or operate machinery.

Montelukast chewable tablet 5 mg contains aspartame

Montelukast chewable tablet contains aspartame, a source of phenylalanine. It may be harmful for you or your children with phenylketonuria. If you or your child has phenylketonuria (a rare, hereditary disorder of the metabolism) you should take into account that each Montelukast chewable tablet contains phenylalanine (equivalent to 0.842 mg phenylalanine per 5 mg chewable tablet).

3. How to take montelukast chewable tablet 5 mg

•    This medicine is to be given to you or a child under adult supervision.

•    You or your child should take only one tablet of Montelukast chewable tablet once a day as prescribed by your doctor.

•    It should be taken even when you or your child has no symptoms or if you or your child has an acute asthma attack.

•    Always take or have your child take Montelukast chewable tablet as your or your child's doctor has told you. You should check with your or your child's doctor or pharmacist if you are not sure.

•    To be taken by mouth.

One Montelukast chewable tablets daily to be taken in the evening. Montelukast chewable tablets should not be taken immediately with food; it should be taken at least 1 hour before or 2 hours after food.

If you or your child is taking Montelukast chewable tablets, be sure that you or your child does not take any other medicines that contain the same active ingredient, montelukast.

If you or your child takes more montelukast chewable tablet 5 mg than you/he/ she should

Contact your or your child's doctor immediately for advice.

There were no side effects reported in the majority of overdose reports. The most frequently occurring symptoms reported with overdose in adults and children included abdominal pain, sleepiness, thirst, headache, vomiting, and hyperactivity.

If you forget to take montelukast chewable tablet 5 mg or give montelukast chewable tablet 5 mg to your child

Try to give or take Montelukast chewable tablets as prescribed. However, if you or your child misses a dose, just resume the usual schedule of one tablet once daily.

Do not give a double dose to make up for a forgotten dose.

If you or your child stops taking montelukast chewable tablet 5 mg

Montelukast chewable tablets can treat you or your child's asthma only if you or your child continues taking it.

L


It is important to continue taking Montelukast chewable tablets for as long as your doctor prescribes. It will help control you or your child's asthma.

If you have any further questions on the use of this product, ask your or your child's doctor or pharmacist.

4. Possible side effects

Like all medicines, Montelukast chewable tablets can cause side effects, although not everybody gets them.

The following terms are used to describe how often side effects have been reported.

Very common: affects more than 1 user in 10 Common: affects 1 to 10 users in 100 Uncommon: affects 1 to 10 users in 1,000 Rare: affects 1 to 10 users in 10,000 Very rare: affects less than 1 user in 10,000 Not known: Frequency cannot be estimated from the available data

In clinical studies with Montelukast chewable tablets, the most commonly reported side effects thought to be related to Montelukast chewable tablets were:

For 5mg:

•    headache

These were usually mild and occurred at a greater frequency in patients treated with Montelukast than placebo (a pill containing no medication).

Additionally, while the medicine has been on the market, the following have been reported:

•    upper respiratory infection(Very common)

•    increased bleeding tendency(Rare)

•    allergic reactions including rash, swelling of the face, lips, tongue, and/or throat which may cause difficulty in breathing or swallowing (Uncommon)

•    behaviour and mood related changes [dream abnormalities, including nightmares, hallucinations, irritability, feeling anxious, restlessness, agitation including aggressive behaviour or hostility, tremor, depression, trouble sleeping, sleep walking, suicidal thoughts and actions (Very rare)]

•    dizziness, drowsiness, pins and needles/numbness, seizure(Uncommon)

•    palpitations(Rare)

•    nose bleeding(Uncommon)

•    diarrhoea, nausea, vomiting (Common); dry mouth, indigestion (Uncommon)

•    hepatitis (inflammation of the liver) (Very rare)

•    Rash (Common); bruising, itching, hives (Uncommon); tender red lumps under the skin most commonly on your shins (erythema nodosum), severe skin reactions (erythema multiforme) that may occur without warning (Very rare)

•    joint or muscle pain, muscle cramps (Uncommon)

•    (Uncommon) tiredness, feeling unwell, swelling, fever (Uncommon)

In asthmatic patients treated with montelukast, very rare cases of a combination of symptoms such as flu-like illness, pins and needles or numbness of arms and legs, worsening of pulmonary symptoms and/or rash (Churg-Strauss syndrome) have been reported. You must tell your doctor right away if you or your child gets one or more of these symptoms.

Ask your doctor or pharmacist for more information about side effects. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your or your child's doctor or pharmacist.

Reporting of side effects If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. By reporting side effects you can help provide more information on the safety of this medicine.

For UK - You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard

For Malta- ADR Reporting The Medicines Authority Post-Licensing Directorate 203 Level 3, Rue D'Argens GZR-1368 Gzira

Website: www.medicinesauthority.gov.mt e-mail: postlicensing.medicinesauthority@gov.mt

6. Contents of the pack and other information

What Montelukast chewable tablets 5 mg contains

•    The active substance is montelukast. Each tablet contains montelukast sodium which corresponds to 5 mg of montelukast.

•    The other ingredients are: mannitol (E421) (SD 200), cellulose, microcrystalline (PH 112), croscarmellose sodium, cherry flavour (501027 AP0551), iron oxide red (E172), aspartame (E951), magnesium stearate

What Montelukast chewable tablets 5 mg looks like and contents of the pack

Pink colored, mottled, round, biconvex tablet, debossed “M5” on one side and plain on other side.

Packaged in OPA-Al-PVC/Al blister.

Pack sizes: 7, 10, 14, 20, 28, 30, 50, 56, 84, 90, 98, 100, 140 and 200 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Accord Healthcare Limited,

Sage House, 319 Pinner Road, North Harrow, Middlesex HA1 4HF, United Kingdom

Manufacturer

Accord Healthcare Limited,

Sage House, 319 Pinner Road, North Harrow, Middlesex

HA1 4HF, United Kingdom or

Cemelog-BRS Ltd., H-2040 Budaors, Vasut u. 13, Hungary

This leaflet was last revised in 02/2014

5. How to store montelukast chewable tablet 5 mg

•    Keep out of the sight and reach of children.

•    Do not use this medicine after the expiry which is stated on the label and carton after EXP. The expiry date refers to the last day of that month.

•    Do not store above 30°C. Store in the original package in order to protect from light and moisture.

•    Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.